U.S. regulators have approved updated COVID-19 shots from Pfizer, Moderna, and Novavax, but access is now limited for younger adults and children to those with high-risk conditions. Pfizer's vaccine is no longer available for children under 5, while Novavax's shot is restricted to those 12 and older. These changes reflect a shift in U.S.